A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 5,199 shares of AXSM stock, worth $452,364. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,199
Previous 5,199 -0.0%
Holding current value
$452,364
Previous $467,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

SELL
$69.39 - $97.64 $44,062 - $62,001
-635 Reduced 10.88%
5,199 $414,000
Q4 2023

Jan 30, 2024

SELL
$57.42 - $83.61 $108,523 - $158,022
-1,890 Reduced 24.47%
5,834 $464,000
Q3 2023

Oct 25, 2023

BUY
$69.25 - $82.21 $60,386 - $71,687
872 Added 12.73%
7,724 $539,000
Q2 2023

Aug 07, 2023

BUY
$58.41 - $90.35 $65,944 - $102,005
1,129 Added 19.73%
6,852 $492,000
Q1 2023

May 08, 2023

BUY
$58.39 - $75.0 $60,200 - $77,325
1,031 Added 21.97%
5,723 $352,000
Q4 2022

Feb 01, 2023

SELL
$39.94 - $79.72 $9,545 - $19,053
-239 Reduced 4.85%
4,692 $361,000
Q3 2022

Nov 09, 2022

BUY
$36.06 - $69.85 $42,082 - $81,514
1,167 Added 31.0%
4,931 $220,000
Q2 2022

Aug 09, 2022

SELL
$21.74 - $46.75 $1,369 - $2,945
-63 Reduced 1.65%
3,764 $144,000
Q1 2022

Apr 21, 2022

BUY
$23.7 - $41.39 $19,694 - $34,395
831 Added 27.74%
3,827 $158,000
Q1 2021

May 03, 2021

SELL
$55.91 - $81.44 $30,135 - $43,896
-539 Reduced 15.25%
2,996 $170,000
Q4 2020

Jan 28, 2021

BUY
$66.31 - $86.52 $33,619 - $43,865
507 Added 16.74%
3,535 $288,000
Q2 2020

Jul 28, 2020

BUY
$49.87 - $98.69 $23,488 - $46,482
471 Added 18.42%
3,028 $249,000
Q1 2020

May 06, 2020

BUY
$41.2 - $101.31 $15,367 - $37,788
373 Added 17.08%
2,557 $150,000
Q3 2019

Oct 18, 2019

SELL
$20.24 - $29.16 $12,285 - $17,700
-607 Reduced 21.75%
2,184 $44,000
Q2 2019

Jul 30, 2019

BUY
$13.46 - $25.75 $37,566 - $71,868
2,791 New
2,791 $72,000

Others Institutions Holding AXSM

About Axsome Therapeutics, Inc.


  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $3.73B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Zurcher Kantonalbank (Zurich Cantonalbank) Portfolio

Follow Zurcher Kantonalbank (Zurich Cantonalbank) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.